Roche keeps Rituxan evergreen with Breakthrough designation, new formulationRoche is finding new ways to keep its oncology and rheumatoid arthritis blockbuster Rituximab/MabThera (rituximab) a big seller, Share XRoche keeps Rituxan evergreen with Breakthrough designation, new formulationhttps://pharmaphorum.com/news/roche-keeps-rituxan-evergreen-breakthrough-designation-new-formulation/